FOXO6 and Insulin resistance: (135) revealed that FOXO6-mediated IL-1β participated in hepatic inflammation and insulin resistance through the tissue factor/protease activated receptor 2 (PAR2) signaling pathway in the liver of FOXO6-knockout mice.